SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending following positive Phase 2 S-OLARIS trial results for sonelokimab in axial spondyloarthritis, which showcased clinically meaningful benefits and objective evidence of disease modification, positioning it as a potential best-in-class therapy. The strong clinical data and a robust cash position are driving community discussions about its significant undervaluation, potential for a short squeeze, and anticipation of further positive updates at its upcoming Investor Day.

Synthetix is a decentralized perpetual futures protocol built on Ethereum Mainnet. Synthetix uses a hybrid design — off-chain order matching on a high-performance CLOB with on-chain settlement — to deliver low latency, deep liquidity, and MEV-resistant execution while keeping custody and finality on Ethereum. Traders get CEX-like performance with on-chain security and composability. The protocol’s liquidity is provided by the Synthetix Liquidity Provider (SLP) vault and backstopped by staked SNX collateral, which underwrites the issuance of the sUSD stablecoin and the solvency of the SLP vault.

Synthetix Network 

Synthetix Network is seeing heightened community excitement driven by its upcoming $1 million trading competition and significant protocol developments, including its full return to Ethereum Mainnet for perps trading. Adding to the bullish sentiment, the community is actively discussing the recent end of SNX token inflation and the impending launch of token buybacks, signaling a major shift in its tokenomics.

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.

Abivax - ADR

Abivax is trending following new positive preclinical and clinical data for its inflammatory bowel disease drug, obefazimod, presented at a major medical congress, which is intensifying rumors of a potential acquisition by major pharmaceutical companies. The community is actively discussing a looming bidding war, with many believing the stock is significantly undervalued despite company denials and official statements to the contrary.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is drawing significant attention as market participants assess the implications of newly implemented 15% global tariffs, leading to polarized community sentiment ranging from predictions of a "bloodbath" amid geopolitical unrest to expectations that the market will quickly rebound, with many also anticipating Nvidia's upcoming earnings.

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Senseonics Holdings Inc

Senseonics is generating buzz following the full commercial availability of its Eversense 365 CGM, now integrated with the twiist AID system, which the community hails as a significant leap with its unique year-long wear and superior accuracy. This pivotal development, coupled with hopes for broader market adoption and potential short squeeze activity, occurs amidst ongoing frustration from investors regarding management's commercial execution.

JFrog Ltd. engages in the provision of an end-to-end, hybrid, universal development operations platform that powers and controls the software supply chain, which enables organizations to continuously and securely deliver software updates across any system. It operates through the following geographical segments: United States, Israel, India, and Rest of World. The firm is also involved in creating software delivered without friction from developer to device. The company was founded by Frederic Simon, Shlomi Ben Haim, and Yoav Landman in 2008 and is headquartered in Sunnyvale, CA.

JFrog Ltd

JFrog ($FROG) is trending following a significant sell-off after Anthropic's Claude Code Security preview, sparking a divided community discussion between those fearing AI disruption and others, including analysts, who view the extreme market reaction as an excessive overcorrection and a buying opportunity for the company's core DevSecOps value.

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, Defense and New Markets. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The New Markets segment includes development, manufacture and sales of small modular reactors (SMRs) and new electrical power solutions. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

Rolls-Royce Holding PLC (ADR)

Rolls-Royce is trending as the community eagerly awaits details on a potential significant share repurchase program and robust annual results, with discussions highlighting the company's strong turnaround across civil aerospace, expanding defense contracts, and emerging opportunities in SMRs and power systems for AI data centers.

The Home Depot, Inc. engages in the sale of building materials and home improvement products. Its products include building materials, home improvement products, lawn and garden products and decor products. The firm operates through the following geographical segments: U.S., Canada and Mexico. It offers home improvement installation services, and tool and rental equipment. The company was founded by Bernard Marcus, Arthur M. Blank, Kenneth Gerald Langone and Pat Farrah on June 29, 1978 and is headquartered at Atlanta, GA.

Home Depot, Inc.

Home Depot is trending after its recent earnings report revealed an EPS miss and a cautious outlook for the coming year, attributed to soft big-ticket consumer spending and a challenging housing market. While some investors view the dip as a long-term buying opportunity given the company's strong Pro segment, others are focused on persistent macroeconomic headwinds and the tempered growth forecast.

ETF Opportunities Trust - TappAlpha SPY Growth & Daily Income ETF

TappAlpha SPY Growth & Daily Income ETF

TSPY, an S&P 500 income ETF leveraging a 0DTE options strategy, is trending amid discussions comparing its ~14% yield and performance against rival funds like SPYI and JEPI. While some users question its recent relative movement, others praise its management and consistent monthly distributions, alongside the debut of new lightly leveraged versions.

Peabody Energy Corp. engages in the business of coal mining. It operates through the following business segments: Seaborne Thermal, Seaborne Metallurgical, Powder River Basin, Other U.S. Thermal, and Corporate and Other. The Seaborne Thermal segment consist of mines in New South Wales, Australia. The Seaborne Metallurgical segment includes mines in Queensland, Australia, one in New South Wales, Australia and one in Alabama, USA. The Powder River Basin segment focuses on mines in Wyoming. The Other U.S. Thermal segment reflects on the mining, preparation and sale of thermal coal, sold primarily to electric utilities in the U.S. under long-term contracts, with a relatively small portion sold as international exports as conditions warrant. The Corporate and Other segment involves administrative expenses, results from equity method investments, trading and brokerage activities, minimum charges on certain transportation-related contracts, the closure of inactive mining sites, the impact of foreign currency remeasurement and certain commercial matters. The company was founded by Francis S. Peabody in 1883 and is headquartered in St. Louis, MO.

Peabody Energy Corp. - Ordinary Shares New

Peabody Energy is trending amidst a surge in bullish sentiment driven by the Trump administration's pro-coal policies, including eased regulations and directives for government coal purchases. The community is also keenly discussing the company's perceived undervaluation, recent rare earth element discoveries, and the positive implications of terminating a large acquisition deal.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Drugs Made In America Acquisition (NASDAQ:DMAA) Stock Price Up 0.1% - Here's Why

Drugs Made In America Acquisition (NASDAQ:DMAA) Trading 0.1% Higher - Still a Buy...

Wolverine Asset Management LLC Buys 227,222 Shares of Drugs Made In America Acquisition Corp. $DMAA

Wolverine Asset Management LLC raised its position in shares of Drugs Made In America Acquisition Corp. (NASDAQ:DMAA - Free Report) by 22.2% in the 3rd quarter, according to the company in its most...

Clear Street LLC Acquires New Shares in Drugs Made In America Acquisition Corp. $DMAA

Clear Street LLC bought a new position in Drugs Made In America Acquisition Corp. (NASDAQ:DMAA - Free Report) in the second quarter, according to the company in its most recent disclosure with the...

DLD Asset Management LP Reduces Position in Drugs Made In America Acquisition Corp. $DMAA

DLD Asset Management LP decreased its holdings in shares of Drugs Made In America Acquisition Corp. (NASDAQ:DMAA - Free Report) by 73.0% during the second quarter, according to the company in its...

Drugs Made In America Acquisition (NASDAQ:DMAA) Trading 0.3% Higher - Should You Buy?

Drugs Made In America Acquisition (NASDAQ:DMAA) Stock Price Up 0.3% - Here's Why...

DMAA
Drugs Made In America Acquisition Corp.

Feed

News

Sentiment

Fundamentals

Info

Latest DMAA News

DMAADrugs Made In America Acquisition Corp.